Jenburkt Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	320.61	259.77	246.07	222.97	165.02
Depreciation & Amortization	25.2	20.63	21.28	17	16.63
Other Amortization	2.08	2.77	1.31	1.98	3.73
Loss (Gain) From Sale of Assets	0.34	0.19	0.49	-0.33	-0.02
Loss (Gain) From Sale of Investments	-8.58	-1.33	-0.04	-0.02	-0.01
Provision & Write-off of Bad Debts	0.79	12.88	5.93	0.84	1.92
Other Operating Activities	-66.32	-31.5	-44.02	-41.82	-45.23
Change in Accounts Receivable	-11.45	-36.86	-15.87	-10.45	36.37
Change in Inventory	-3.19	-2.24	15.5	-23.06	33.17
Change in Accounts Payable	18.98	1.6	-10.14	25.18	-16.14
Change in Other Net Operating Assets	0.6	-144.68	-49.99	-99.57	-0.89
Operating Cash Flow	279.06	81.24	170.52	92.71	194.55
Operating Cash Flow Growth	243.51%	-52.36%	83.92%	-52.34%	29.55%
Capital Expenditures	-197.14	-25.54	-21.05	-30.54	-11.45
Sale of Property, Plant & Equipment	-	-	0	5.06	0.3
Investment in Securities	1,501	1,204	31.84	-37.3	-214.78
Other Investing Activities	-1,474	-1,184	15.38	50.75	38.12
Investing Cash Flow	-170.45	-5.8	26.18	-12.02	-187.81
Long-Term Debt Repaid	-5.61	-5.1	-5.1	-5.1	-5.1
Net Debt Issued (Repaid)	-5.61	-5.1	-5.1	-5.1	-5.1
Repurchase of Common Stock	-	-	-145.15	-	-
Common Dividends Paid	-67.81	-63.18	-55	-46.8	-
Other Financing Activities	-2.8	-2.5	-5.17	-3.41	-2.04
Financing Cash Flow	-76.22	-70.78	-210.41	-55.31	-7.14
Net Cash Flow	32.39	4.66	-13.71	25.38	-0.4
Free Cash Flow	81.92	55.7	149.48	62.17	183.1
Free Cash Flow Growth	47.09%	-62.74%	140.43%	-66.05%	75.00%
Free Cash Flow Margin	5.40%	3.92%	10.93%	5.01%	16.75%
Free Cash Flow Per Share	18.56	12.62	32.74	13.55	39.90
Cash Interest Paid	2.8	2.5	5.16	3.41	3.48
Cash Income Tax Paid	134.33	82.63	82.24	75.61	58.37
Levered Free Cash Flow	87.39	182.75	131.18	143.35	166.54
Unlevered Free Cash Flow	89.76	184.19	133.05	145.52	169.19
Change in Working Capital	4.94	-182.17	-60.5	-107.91	52.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.